SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-031804
Filing Date
2021-12-17
Accepted
2021-12-17 08:15:14
Documents
14
Period of Report
2021-12-16
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 48510
2 ex99-1.htm EX-99.1 14858
  Complete submission text file 0001493152-21-031804.txt   285424

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE adxs-20211216.xsd EX-101.SCH 3746
4 XBRL DEFINITION FILE adxs-20211216_def.xml EX-101.DEF 26613
5 XBRL LABEL FILE adxs-20211216_lab.xml EX-101.LAB 36635
6 XBRL PRESENTATION FILE adxs-20211216_pre.xml EX-101.PRE 25231
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5532
Mailing Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852
Business Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852 732 545 1590
Advaxis, Inc. (Filer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 001-36138 | Film No.: 211499583
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences